Experienced in Erysipeloid

Dr. Craig R. Lewis

Internal Medicine
80 Main St, Central Plaza, 
Livermore Falls, ME 
Experienced in Erysipeloid
80 Main St, Central Plaza, 
Livermore Falls, ME 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Lewis is a primary care provider, practicing in Internal Medicine in Livermore Falls, Maine. Dr. Lewis is rated as an Experienced provider by MediFind in the treatment of Erysipeloid. His top areas of expertise are Peripheral Neuropathy, Neurotoxicity Syndromes, Lung Cancer, and Type 2 Diabetes (T2D).

His clinical research consists of co-authoring 44 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in ME
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

80 Main St, Central Plaza, Livermore Falls, ME 04254

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Double Blind, Randomized, Controlled Study of M7824 With Concurrent Chemoradiation Followed by M7824 Versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants With Unresectable Stage III Non-small Cell Lung Cancer
A Multicenter, Double Blind, Randomized, Controlled Study of M7824 With Concurrent Chemoradiation Followed by M7824 Versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants With Unresectable Stage III Non-small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: M7824, Durvalumab, Etoposide, Pemetrexed, Carboplatin, Paclitaxel, Cisplatin
Study Phase: Phase 2

44 Total Publications

Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data.
Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data.
Journal: Frontiers in oncology
Published: November 17, 2023
Similar Doctors
Advanced in Erysipeloid
Dr. Christopher P. Hjorth
Internal Medicine
Advanced in Erysipeloid
Dr. Christopher P. Hjorth
Internal Medicine

Mainehealth

108 Centre St, 
Bath, ME 
 (43.1 miles away)
Languages Spoken:
English
See accepted insurances

Christopher Hjorth is a primary care provider, practicing in Internal Medicine in Bath, Maine. Dr. Hjorth is rated as an Advanced provider by MediFind in the treatment of Erysipeloid. His top areas of expertise are Erysipeloid, Trigeminal Neuralgia, Adult Still's Disease, and Glucocorticoid-Remediable Aldosteronism.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lewis's expertise for a condition
ConditionClose
        View All 24 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile